Palomar (NASDAQ:PLMR) Insider Angela Grant Sells 365 Shares

by · The Cerbat Gem

Palomar Holdings, Inc. (NASDAQ:PLMR – Get Free Report) insider Angela Grant sold 365 shares of the stock in a transaction on Thursday, January 29th. The shares were sold at an average price of $122.04, for a total value of $44,544.60. Following the transaction, the insider directly owned 6,580 shares in the company, valued at $803,023.20. The trade was a 5.26% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Palomar Price Performance

Shares of PLMR traded up $0.63 during trading hours on Monday, hitting $124.22. The stock had a trading volume of 240,836 shares, compared to its average volume of 180,129. The firm has a market capitalization of $3.29 billion, a PE ratio of 19.38 and a beta of 0.44. Palomar Holdings, Inc. has a 12 month low of $104.47 and a 12 month high of $175.85. The stock has a fifty day moving average price of $127.67 and a 200 day moving average price of $123.57.

Palomar (NASDAQ:PLMR – Get Free Report) last posted its earnings results on Thursday, November 6th. The company reported $2.01 earnings per share for the quarter, beating analysts’ consensus estimates of $1.56 by $0.45. The company had revenue of $244.66 million for the quarter, compared to the consensus estimate of $207.98 million. Palomar had a return on equity of 21.93% and a net margin of 22.59%.During the same quarter in the prior year, the company earned $1.23 earnings per share. As a group, analysts anticipate that Palomar Holdings, Inc. will post 5.99 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Artemis Investment Management LLP raised its holdings in shares of Palomar by 12.8% during the 4th quarter. Artemis Investment Management LLP now owns 212,279 shares of the company’s stock worth $28,607,000 after acquiring an additional 24,169 shares in the last quarter. Horizon Investments LLC purchased a new position in shares of Palomar in the fourth quarter valued at $111,000. Danske Bank A S increased its position in Palomar by 69.9% in the fourth quarter. Danske Bank A S now owns 138,295 shares of the company’s stock worth $18,637,000 after purchasing an additional 56,898 shares during the last quarter. Conestoga Capital Advisors LLC increased its position in Palomar by 17.3% in the fourth quarter. Conestoga Capital Advisors LLC now owns 20,635 shares of the company’s stock worth $2,781,000 after purchasing an additional 3,050 shares during the last quarter. Finally, PVG Asset Management Corp purchased a new stake in Palomar during the fourth quarter valued at $218,000. Hedge funds and other institutional investors own 90.25% of the company’s stock.

Palomar News Roundup

Here are the key news stories impacting Palomar this week:

  • Positive Sentiment: Palomar closed the acquisition of The Gray Casualty & Surety Company, expanding its surety capabilities and product mix — a strategic tuck‑in that can add premium, diversify risk exposure and support growth in specialty lines. BCP Completes Sale of The Gray Casualty & Surety Company
  • Neutral Sentiment: Palomar will report Q4 and full‑year 2025 results after the close on Feb 11, 2026, with a conference call Feb 12 — an event that typically drives short‑term volume and volatility as investors update estimates and listen for management commentary on reserve development, underwriting margin, and growth. Earnings Release & Conference Call
  • Negative Sentiment: Multiple insiders (including the CEO, President, CFO and other senior executives) sold shares on Jan. 29 and Jan. 31, reducing positions by low-single-digit percentages in many cases. Heavy insider selling can signal liquidity taking or tax/comp planning, but it may concern some investors about insider confidence or timing ahead of earnings. Representative coverage of recent insider sales is here. CEO Sells Stock (Example)

Wall Street Analyst Weigh In

PLMR has been the subject of a number of research reports. Wall Street Zen raised shares of Palomar from a “hold” rating to a “buy” rating in a report on Saturday, January 10th. JPMorgan Chase & Co. boosted their price objective on shares of Palomar from $145.00 to $155.00 and gave the company an “overweight” rating in a research report on Wednesday, January 7th. Weiss Ratings upgraded Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, January 14th. Finally, Keefe, Bruyette & Woods lifted their target price on Palomar from $170.00 to $171.00 and gave the company an “outperform” rating in a research report on Tuesday, January 6th. Six equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $159.50.

Read Our Latest Report on PLMR

About Palomar

(Get Free Report)

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.

Recommended Stories